GlassScriptPhysician profile
Matthew Ryan Grafenberg
NPI 1225001357
$8,517.07
in general payments reported to CMS, 2019-2025
25 companies · $830 in 2025
The $830 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,555 · 2020: $1,363 · 2021: $1,104 · 2022: $1,541 · 2023: $1,303 · 2024: $822 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,810 · Consulting Fee: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,809.91 |
| Consulting Fee | $145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,514.06 | 2020-2025 | Inspire |
| Aerin Medical INC. | $1,272.25 | 2019-2025 | |
| Acclarent, INC | $990.42 | 2019-2023 | Trudi Nav Cable |
| Medtronic, INC. | $695.23 | 2021-2024 | Propel, Nuvent, Straightshot |
| Glaxosmithkline, LLC. | $675.55 | 2020-2025 | Nucala |
| Medical Device Business Services, INC. | $572.94 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $381.51 | 2020-2025 | Dupixent |
| Genzyme Corporation | $308.65 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $252.41 | 2019-2021 | |
| Intersect Ent, INC. | $216.74 | 2019-2022 | |
| Axsome Therapeutics, INC. | $182.66 | 2023-2025 | Sunosi |
| Med-El Corporation | $89.36 | 2019 | |
| Merck Sharp & Dohme LLC | $61.40 | 2022-2025 | Keytruda, Keytruda Qlex |
| Stryker Corporation | $59.84 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $55.91 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $36.45 | 2021-2024 | |
| Itamar Medical INC | $29.23 | 2025 | Watchpatone |
| Kaleo, INC. | $26.76 | 2021 | |
| Smith+Nephew, INC. | $17.77 | 2021 | |
| Integra Lifesciences Corporation | $16.75 | 2023 | Integra Duo, Instruments-Orthopedic, Codman Isocool Aht |
| Alk-Abello, INC | $15.37 | 2020 | |
| Hikma Pharmaceuticals USA | $14.19 | 2024 | Ryaltris |
| Medtronic USA, INC. | $13.18 | 2019 | |
| Cochlear Americas | $12.59 | 2022 | |
| Forte Bio-Pharma LLC | $5.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Grafenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.